Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK
Physiology and Internal Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
BMJ Open. 2022 Apr 26;12(4):e051267. doi: 10.1136/bmjopen-2021-051267.
To determine the association between baseline kidney function and subsequent all-cause mortality.
A general population-based cohort study from rural Uganda.
People aged 18 years and above with measured baseline estimated glomerular filtration rate (eGFR), recruited from survey rounds in 2011-2012 or 2014-2015 and followed up to March 2019.
The primary outcome was all-cause mortality, identified through reports from community health workers and verified by verbal autopsy. The association between baseline eGFR category and mortality was determined using multivariable Cox regression.
Of 5812 participants in both rounds, we included 5678 (97.7%) participants with kidney function and mortality data; the median age was 36 years (IQR 24-50), 60.7% were female, 10.3% were hypertensive, 9.8% were HIV-positive and 1.5% were diabetic. During a median follow-up of 5.0 years (IQR 3.7-6.0) there were 140 deaths. In age-adjusted and sex-adjusted analyses, eGFR <45 mL/min/1.73 m at baseline was associated with a 5.97 (95% CI 2.55 to 13.98) increased risk of mortality compared with those with baseline eGFR >90 mL/min/1.73 m. After inclusion of additional confounders (HIV, body mass index, diabetes, hypertension, alcohol and smoking status) into the model, eGFR <45 mL/min/1.73 m at baseline remained strongly associated with mortality (HR 6.12, 95% CI 2.27 to 16.45), although the sample size fell to 3102. Test for trend showed strong evidence (p<0.001) that the rate of mortality increased progressively as the category of baseline kidney function decreased. When very high eGFR was included as a separate category in age-adjusted and sex-adjusted analyses, baseline eGFR ≥120 mL/min/1.73 m was associated with increased risk of mortality (HR 2.68, 95% CI 1.47 to 4.87) compared with the reference category of 90-119 mL/min/1.73 m.
In a prospective cohort in rural Uganda we found that impaired baseline kidney function was associated with subsequently increased total mortality. Improved understanding of the determinants of kidney disease and its progression is needed in order to inform interventions for prevention and treatment.
确定基线肾功能与随后全因死亡率之间的关联。
乌干达农村的一项基于一般人群的队列研究。
年龄在 18 岁及以上、基线估算肾小球滤过率(eGFR)有测量值的人群,从 2011-2012 年或 2014-2015 年的调查轮次招募,并随访至 2019 年 3 月。
主要结局为全因死亡率,通过社区卫生工作者的报告确定,并通过口头尸检进行验证。使用多变量 Cox 回归确定基线 eGFR 类别与死亡率之间的关系。
在两轮研究中,我们共纳入了 5812 名参与者中的 5678 名(97.7%)有肾功能和死亡率数据的参与者;中位年龄为 36 岁(IQR 24-50),60.7%为女性,10.3%为高血压患者,9.8%为 HIV 阳性,1.5%为糖尿病患者。在中位随访 5.0 年(IQR 3.7-6.0)期间,有 140 人死亡。在年龄调整和性别调整分析中,与基线 eGFR >90 mL/min/1.73 m 的参与者相比,基线时 eGFR <45 mL/min/1.73 m 与死亡风险增加 5.97 倍(95%CI 2.55 至 13.98)相关。在将 HIV、体重指数、糖尿病、高血压、酒精和吸烟状况等其他混杂因素纳入模型后,基线时 eGFR <45 mL/min/1.73 m 与死亡率仍高度相关(HR 6.12,95%CI 2.27 至 16.45),尽管样本量降至 3102。趋势检验显示,随着基线肾功能类别降低,死亡率呈明显递增趋势(p<0.001)。当非常高的 eGFR 被单独归类为一个类别并在年龄调整和性别调整分析中进行分析时,与参考类别 90-119 mL/min/1.73 m 相比,基线 eGFR ≥120 mL/min/1.73 m 与死亡风险增加相关(HR 2.68,95%CI 1.47 至 4.87)。
在乌干达农村的一项前瞻性队列研究中,我们发现基线肾功能受损与随后的总死亡率增加有关。需要更好地了解肾脏疾病及其进展的决定因素,以便为预防和治疗提供信息。